SEC Form 4/A · accession 0000899243-15-005212
REGENXBIO Inc. · RGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Argeris N Karabelas
Director
Period of report
Sep 16, 2015
Accepted (ET)
Sep 22, 2015 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $22.00 | Sep 16, 2015 | A | 9,375 | A | — | Sep 16, 2025 | Common Stock | 9,375 | 9,375 | D |
Explanation of responses
- F1The Number of Derivative Securities Acquired, the Amount of Underlying Securities and the Number of Derivative Securities Beneficially Owned Following Reported Transaction were inadvertently misreported by the Reporting Person on the Form 4 file on September 17, 2015.
- F2The option will vest in equal monthly installments over the 12 months following September 16, 2015, with immediate full vesting in the event of a change in control.